Socialiya - Entertainment. Knowledge. Community.
FDA’s top gene therapy regulator is leaving his role

WASHINGTON — Vijay Kumar, acting director of the office that reviews cell and gene therapies at the...

BUSINESS NEWS June 29, 2026

FDA’s top gene therapy regulator is leaving his role

WASHINGTON — Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is stepping down from his...

2 views 0 likes 0 comments
Share:
WASHINGTON — Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is stepping down from his...

Author: statnews.com

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya